Posters simples

Jour 1 : Mardi 12 juin 2018

  • PS1 - 001 - Safety case reports analysis of progestin-only contraceptives within the French Pharmacovigilance Database. - Anne DAUTRICHE (Dijon)
  • PS1 - 002 - Differential targeted impact of hydroxyurea and ropeginterferon alfa-2b on tumor clones in Polycythemia Vera - Lydia ROY (Créteil)
  • PS1 - 003 - Liposomal amphotericin B pharmacokinetics in a patient with invasive pulmonary aspergillosis treated by extracorporeal membrane oxygenation - Florian LEMAITRE (Rennes)
  • PS1 - 004 - Vasorelaxant effects of Eulophia macrobulbon and its main compound in rat mesenteric arteries - Sutthinee WISUTTHATHUM (Phitsanulok)
  • PS1 - 005 - Risperidone-induced metabolic dysfunction is attenuated by Curcuma longa extract administration in mice - Olivier PETRAULT (Lille)
  • PS1 - 006 - Antipsychotics induced-camptocormia: a case-series - Mélissa YÉLÉHÉ-OKOUMA (Nancy)
  • PS1 - 007 - Management of the interaction between lumacaftor/ivacaftor and antifungal prophylaxis in patients with cystic fibrosis - Christelle BOGLIONE-KERRIEN (Rennes)
  • PS1 - 008 - Use of opioid substitution therapy: the patient's point of view - Marion LEPELLEY (Grenoble)
  • PS1 - 009 - Cirrhotic patients in ICU with gastro-intestinal bleeding managed according to recent guidelines display altered brain hemoglobin oxygen's saturation assessed by near infrared spectroscopy. - Nicolas WEISS (Paris)
  • PS1 - 010 - Unexpected low plasma levels of posaconazole with the gastro-resistant tablet : influence of pre-analytical conditions - Peggy GANDIA (Toulouse)
  • PS1 - 011 - Quality control in vigilance database: a tool to guarantee data quality and patient safety in clinical trials - Julie FRESSARD (Lyon)
  • PS1 - 012 - Clinical consequences related to defective elimination of clobazam caused by homozygous mutated CYP2C19 allele: a case report - David BOELS (Angers)
  • PS1 - 013 - Acute posterior multifocal placoid pigment epitheliopathy after vaccination: Review of the literature and analysis of the French Pharmacovigilance database - Jérémy MANGAVELLE (Saint-Etienne)
  • PS1 - 014 - Lack of effects of simvastatin on smoking cessation in humans: A double-blind, randomized, placebo-controlled clinical study - Claire LAFAY-CHEBASSIER (Poitiers)
  • PS1 - 015 - Use of cabazitaxel in treatment of metastatic Castration-Resistant Prostate Cancer (mCRPC): patient characteristics, safety and effectiveness in the FUJI cohort - Annie FOURRIER-RÉGLAT (Bordeaux)
  • PS1 - 016 - 99m-Tc dimercaptosuccinic acid renal scintigraphy time course allows assessment of interstitial fibrosis development during adenine rich diet in rats. - Guillaume HACHE (Marseille)
  • PS1 - 017 - Delayed eruptions with photosensitivity induced by intravenous immunoglobulin infusions - Sandrine COMBRET (Dijon)
  • PS1 - 018 - Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire. - Jean Claude YAVO (Abidjan)
  • PS1 - 019 - Comparative efficacy of treatments for secondary Raynaud’s phenomenon: a systematic review and network meta-analysis of randomized trials - Charles KHOURI (Grenoble)
  • PS1 - 020 - A comparative study about drug safety in oncology and frail patients - Malak ABOU TAAM (Reims)
  • PS1 - 021 - Free prednisolone pharmacokinetics after oral prednisone administration in patients with inflammatory - immunonologic conditions - Olivier MANGIN (Paris)
  • PS1 - 022 - Implementation of a national pharmacovigilance system and drug risk management in a French-speaking African country, Côte d'Ivoire : Review and Prospects - Jean Claude YAVO (Abidjan)
  • PS1 - 023 - Role of phosphodiesterases in controlling cGMP compartmentation in cultured vascular smooth muscle cells - Véronique LEBLAIS (Châtenay-Malabry)
  • PS1 - 024 - Prevention of invasive Aspergillus fungal infections with the suspension and delayed-release tablet formulations of posaconazole in patients with haematologic malignancies - Noël ZAHR (Paris)
  • PS1 - 025 - Evaluation of the effect of benzodiazepines on cognitive status in rats - Youness KADIL (Casablanca)
  • PS1 - 026 - Urinary retention: a side effect of Terbinafine? - Marie TRIGUER (Caen)
  • PS1 - 027 - Reported vaccination side effects in Franche-Comte over a five-year period - Melanie MOLTENIS (Besancon)
  • PS1 - 028 - Thyroiditis and immune check point inhibitors: a national descriptive retrospective non-interventional study based on the French Pharmacovigilance Database - Julie GARON CZMIL (Nancy)
  • PS1 - 029 - Use of the French health insurance database for research in the field of mental health: review and perspectives - Alexis REVET (Toulouse)
  • PS1 - 030 - Effect of an High Fat Diet and Vitamin D3 supplementation in the aortic valvulopathy EGFrwa2/wa2 murin model - Bérénice COLLEVILLE (ROUEN)
  • PS1 - 031 - Audit concerning the medicinal care of elderly patients in a teaching hospital - Juliette DINET (Rouen)
  • PS1 - 032 - Impact of a cortical microbleed on cognition and its pharmacological modulation by atorvastatin in female wild-type and transgenic mice - Romain BARUS (Lille)
  • PS1 - 033 - Diabetes in a patient with Gaucher disease: adverse drug reaction or disease progression? - Louise GABORIAU (Lille)
  • PS1 - 034 - Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction - Lamiae GRIMALDI-BENSOUDA (Paris)
  • PS1 - 035 - Leflunomide for BKvirus: serie of 7 kidney-transplanted children - Manon LAUNAY (Paris)
  • PS1 - 036 - Dermatological adverse drug reactions of anticancer drug: international data of pharmacovigilance (VigiBase®)· - Mathilde STRUMIA (Toulouse)
  • PS1 - 037 - Work interruption in a short-term hospital service: A risk factor for medication error - Juliette DINET (Rouen)
  • PS1 - 038 - Topical clobetasol induced necrotizing fasciitis after bullous pemphigoid: case report and review of literature - Louise GABORIAU (Lille)
  • PS1 - 039 - Implication of the blood-brain barrier in the physiopathology of hepatic encephalopathy in cirrhosis - Nicolas WEISS (Paris)
  • PS1 - 040 - Cyamemazine-induced peripheral edema: a case report - Karine BERQUET (Nantes)
  • PS1 - 041 - Adverse drug reactions of statins in a paediatric population: a descriptive analysis of individual case safety reports from VigiBase® - Cécile CONTE (Toulouse)
  • PS1 - 042 - Misuse of trihexyphenidyl (Artane®) on Réunion island - Romain TORRENTS (Marseille)
  • PS1 - 043 - Comparison between voriconazole trough concentration in children and adults - Imed MTAR (Tunis)
  • PS1 - 044 - Risk assessment in morphine sulfate off-label use in non-painful opioid dependent patients - Célian BERTIN (Clermont-Ferrand)
  • PS1 - 045 - Direct oral anticoagulant-induced hallucination: review of the French Pharmacovigilance Database. - Johana BÉNÉ (Lille)
  • PS1 - 046 - Confusional state induced by quetiapine - Paul DELAUNAY (Poitiers)
  • PS1 - 047 - Differential pharmacokinetic interaction of cyclosporine and tacrolimus with colchicine in renal allograft recipients - laurent BECQUEMONT (Kremlin Bicêtre)
  • PS1 - 048 - E-cigarette: a new fashionable, discreet, but risky way to misuse drugs - Basile CHRÉTIEN (Caen)
  • PS1 - 049 - Post-marketing surveillance of Arcoxia® (etoricoxib) safety: a 6.5-year follow-up study in France - Marie ZENUT (Clermont-Ferrand)
  • PS1 - 050 - Assessment of pre-analytical nonconformities in a laboratory of clinical pharmacology - Issam SALOUAGE (Tunis)
  • PS1 - 051 - Does imatinib also slow ALL children patients’ growth down? about 2 case reports - Lucie POUCHÉ (Bordeaux)
  • PS1 - 052 - ADR involving metoclopramide in children after the indication restriction in 2012: an ongoing issue - Farid KHELOUFI (Marseille)
  • PS1 - 053 - Descriptive analysis of the methods of administration of injectable cytotoxic drugs in hospitals - Imane RAHMOUNE (Casablanca)
  • PS1 - 054 - Multimodal approach including MR-spectroscopy for the diagnosis of minimal hepatic encephalopathy - Nicolas WEISS (Paris)
  • PS1 - 055 - Observational study of the management of patients with chronic pain: OKAPI study - Alexandrine CORRIGER (Clermont-Ferrand)
  • PS1 - 057 - Preventability of serious adverse drug reactions in the elderly: analysis of the spontaneous reports to a French pharmacovigilance center over 10 years - Marion LEPELLEY (Grenoble)
  • PS1 - 058 - Comparison of drug-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in French and Vietnamese database (2010-2015) - Khac-Dung NGUYEN (Toulouse)
  • PS1 - 059 - Quetiapine-induced immune thrombocytopenia: one case report with two positive rechallenges - Anaïs GAIFFE (Besançon)
  • PS1 - 060 - Paliperidone palmitate induced hyponatremia: a fatal case - anne BERNARD (Nantes)
  • PS1 - 061 - The drugs that mostly frequently induce gynecomastia : a case–non case study of a pharmacovigilance database - Benjamin BATTEUX (Amiens)
  • PS1 - 062 - Change of clinical trial vigilance software in 6 university hospitals of western France : an experience of data migration - Catherine MOUCHEL (Rennes)
  • PS1 - 063 - Acute hepatitis in a regular user of inhaled cocaine: a case report - Emilie BOUQUET (Poitiers)
  • PS1 - 064 - Association between venous thromboembolism events and fibrates: a comparative study. - Joachim ALEXANDRE (Caen)
  • PS1 - 065 - Terpenes derivatives and risk of seizure: be careful with self-medication! - Basile CHRETIEN (Caen)
  • PS1 - 068 - Always check chemical structures in case of reintroduction after a serious adverse reaction: about a case of bronchiolitis obliterans organizing pneumonia with decitabine - Julie LEBRUN (Montpellier)
  • PS1 - 069 - Non-cancer drug consumption during the early trajectory of lymphoma survivorship - Fabien DESPAS (Toulouse)
  • PS1 - 070 - The course of psychotropic drug use in lymphomas: a pharmaco-epidemiological study in the French Health insurance database - Cécile CONTE (Toulouse)
  • PS1 - 071 - Post-marketing surveillance of celecoxib safety: a 12-year follow-up study in France - Marie ZENUT (Clermont-Ferrand)
  • PS1 - 072 - Therapeutic drug monitoring as a tool for Assessment of drug interaction between lamotrigine and other antiepileptic drugs - mouna BEN SASSI (Tunis)
  • PS1 - 073 - Exacerbation of a hypocalcemia associated with short term use of omeprazole - Sihem EL-AIDLI (Tuns)
  • PS1 - 074 - Is the use of bupivacaine for femoral block by neurostimulation safe? - Issam SALOUAGE (Tunis)
  • PS1 - 075 - A young woman presenting a Kikuchi-Fujimoto's disease associated with Drug-Induced Lupus - Galith KALMI (Paris)
  • PS1 - 076 - Leukocytoclastic vasculitis induced by lercanidipine - Sihem EL-AIDLI (Tunis)
  • PS1 - 077 - Early onset of cognitive impairment associated with valproic acid - Sihem EL-AIDLI (Tunis)
  • PS1 - 078 - A high performance liquid chromatography tandem mass spectrometry method for the quantification of eight tyrosine kinase inhibitors in human plasma. - Camille TRON (Rennes)
  • PS1 - 079 - Strategy to reduce cholesterol – a review of two approaches: target and fixed-dosage - François GUEYFFIER (Lyon)

 

Jour 2 : Mercredi 13 juin 2018 

  • PS2 - 001 - Hydroxyzine and QT prolongation: three studies in real life - Sophie FEDRIZZI (Caen)
  • PS2 - 002 - Pharmacokinetic-Pharmacogenetic exploration of patients presenting unexpected high levels of isavuconazole - Lea DARNAUD (Toulouse)
  • PS2 - 003 - Determination of Dolutegravir, Darunavir and Atazanavir unbound fraction in HIV patients by equilibrium dialysis and ultrafiltration using a LC-MS method - David METSU (Toulouse)
  • PS2 - 004 - Trends of atropinic (anticholinergic) exposure in the elderly: a ten-year analysis in the French EGB database - Sibylle DE GERMAY (Toulouse)
  • PS2 - 005 - Drug-induced skin ulcer: a disproportionality analysis using data from VigiBase® - Dorothée DURON (Grenoble)
  • PS2 - 006 - Relationship Between Adverse Drug Reactions and Unlicensed/Off-label Drug Use in Hospitalized Children (EREMI) - Behrouz KASSAI (Lyon)
  • PS2 - 007 - Drug exposure and risk of Acute Liver Failure leading to registration for liver Transplantation (ALFT): results of the SALT-III study in adults in France - Nicholas MOORE (Bordeaux)
  • PS2 - 008 - Increase of hospital admission related to cocaine use: results from the national hospital discharge database - Céline EIDEN (Montpellier)
  • PS2 - 009 - Blood-brain barrier dysfunction assessed by Protein S-100 beta levels in cirrhotic patients in ICU. - Nicolas WEISS (Paris)
  • PS2 - 010 - The influenza vaccination coverage among hospital workers: difference in behaviour between medical staff and others health-care workers. - Gabriel BERTOLIATTI (Rouen)
  • PS2 - 011 - Effectiveness of statins according to cardiovascular risk in the elderly - Julien BEZIN (Bordeaux)
  • PS2 - 012 - Complying to the new Jardé law: getting help from an “old” friend. Lessons from the BACLOPHONE trial. - Céline LECLERCQ (Lille)
  • PS2 - 013 - Misuse of androgenic anabolic steroids by body builders and hepatotoxicity - Aude LAMBERT (Strasbourg)
  • PS2 - 014 - Comparison of the adverse effects of direct oral anticoagulants and vitamin K antagonists : from a study conducted at the Regional Pharmacovigilance Center of Reims. - Brahim AZZOUZ (Reims)
  • PS2 - 015 - Successful rechallenge of rituximab after immediate reaction - AHMED ZAIEM (Tunis)
  • PS2 - 016 - Social media screening in pharmacovigilance activities: a new approach - Noémie SCHILLER (Pierre-Bénite)
  • PS2 - 017 - Off-label use during pregnancy: analysis of the Néhavi cohort - Marie-Laure LAROCHE (Limoges)
  • PS2 - 018 - SGLT-2 inhibitors and the risk of lower-limb amputation: is this a class effect? - Charles KHOURI (Grenoble)
  • PS2 - 019 - Pharmacokinetic adaptations of antibiotic posology: sampling errors in patients with continuous infusion of vancomycin in an university hospital - Sylvain COUDERC (Limoges)
  • PS2 - 020 - Adverse Drug Reactions associated with protease inhibitors in children: a comparison of Atazanavir versus Darunavir using data from VigiBase - Joe MIANTEZILA BASILUA (Paris)
  • PS2 - 021 - Drug iatrogenic disease and recourse to the adult psychiatric emergencies - Emilie TERRO (Rouen)
  • PS2 - 022 - Hormonal therapy-induced meningioma - Aurélie FÉRAL (Amiens)
  • PS2 - 023 - Take-home intranasal naloxone: results of one year prescription at an addiction care center - Céline EIDEN (Montpellier)
  • PS2 - 024 - Tacrolimus individual dose adjustment using population pharmacokinetics model - Issam SALOUAGE (Tunis)
  • PS2 - 025 - Vomiting and constipation associated with tramadol or codeine in VigiBase®: differences explained by pharmacodynamic properties - Jean-Louis MONTASTRUC (Toulouse)
  • PS2 - 026 - Safety profiles of BRAF-inhibitors and MEK-inhibitors: analysis of the WHO database of adverse drug reactions, VigiBase® - Marine ROUSSET (Bordeaux)
  • PS2 - 027 - Intracellular lithium dosing: which pertinence? - Caroline VICTORRI-VIGNEAU (Nantes)
  • PS2 - 028 - Validation of a simple and rapid HPLC-DAD method for the routine therapeutic drug monitoring of ceftolozane in critically ill patients - Youssef BENNIS (Amiens)
  • PS2 - 029 - Level of pharmacological knowledge of street drug sellers - Mamadou KAMAGATE (Bouaké)
  • PS2 - 030 - Curcuma longa extract inhibits risperidone induced metabolic abnormalities in mice - Olivier PETRAULT (Lille)
  • PS2 - 031 - Development of a document to aid sites to report adverse events in clinical trials - Anaïs EL HACHEMI (Pierre-Bénite)
  • PS2 - 032 - Current prescription practices of antipsychotics in the treatment of psychotic disorders in the psychiatric hospital of Nancy, France - Juliana TOURNEBIZE (Nancy)
  • PS2 - 033 - Dietary supplement consumption leading to hospitalisations: case series - Louise GABORIAU (Lille)
  • PS2 - 034 - Real-life treatment and survival in metastatic colorectal cancer elderly patients: a French population-based study - Amandine GOUVERNEUR (Bordeaux)
  • PS2 - 035 - Drug-induced Trigeminal Autonomic Cephalgia (TAC) in the French Pharmacovigilance database - Marie-Noëlle BEYENS (Saint Etienne)
  • PS2 - 036 - Psychoactive Substance consumption among teenagers: Results from Addictovigilance monitoring - Liselotte POCHARD (Marseille)
  • PS2 - 037 - Evaluation of direct oral anticoagulants (DOAC) prescriptions at St Etienne University Hospital Center - Pierre BRUNEL (Saint-Etienne)
  • PS2 - 038 - Drug-induced Pisa syndrome: a literature review - Céline LENGELLÉ (Tours)
  • PS2 - 039 - Dose-dependent kinetic analysis of metabolite changes after ethanol intoxication in rat prefrontal cortex using in vivo magnetic resonance spectroscopy - Louise CARTON (Lille)
  • PS2 - 040 - Risk of Vaccine-Induced Immune Thrombocytopenia in Children. A nationwide case cross-over study in France - Agnès SOMMET (Toulouse)
  • PS2 - 041 - Vicks® VapoRub: use, misuse and risks - Johana BÉNÉ (Lille)
  • PS2 - 042 - Self medication by NPS in a patient with adult ADHD - Olivier MENARD (Lille)
  • PS2 - 043 - Adverse reactions associated with hepatitis C treatment - AHMED ZAIEM (Tunis)
  • PS2 - 044 - Drug-induced acute liver injury (ALI) in the French claims database: description of cases - Nicholas MOORE (Bordeauc)
  • PS2 - 045 - Contribution of NO and Impact of aging in flow mediated dilatation in healthy patients: meta-analysis and meta-regression - Zoubir DJERADA (Rouen/reims)
  • PS2 - 046 - Phenobarbital induced DRESS syndrome: an atypical presentation - AHMED ZAIEM (Tunis)
  • PS2 - 047 - Leuprorelin and ulceration at the site of injection: about three serious cases - Julie LEBRUN (Montpellier)
  • PS2 - 048 - Development and validation of a specific, high-range, high-throughput enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab - Antoine PETITCOLLIN (Rennes)
  • PS2 - 049 - Hepatic cytolysis and acute hepatic failure induced by a triple drug interaction (ponatinib, voriconazole, azithromycine): a case report - Delphine BOURNEAU-MARTIN (Angers)
  • PS2 - 050 - Effect of CYP3A5, CYP3A4 and ABCB1 polymorphisms on tacrolimus exposure in renal transplantation patients - Marwa AJMI (Sousse)
  • PS2 - 051 - Should imatinib regimen be adapted and monitored in CML children patients? Experience initiated from a case report - Stephane BOUCHET (Bordeaux)
  • PS2 - 052 - Adverse drug reactions related to drug-drug interactions: lower severity level of drug drug interactions and pharmacodynamic interactions are oversighted - Farid KHELOUFI (Marseille)
  • PS2 - 053 - Implication of the antidepressants in sexual dysfunctions in patients with major depressive disorder - Caroline VICTORRI-VIGNEAU (Nantes)
  • PS2 - 054 - Drugs, Adverse Drug Reactions and PharmacoVigilance in the Adventures of Tintin - Jean-Louis MONTASTRUC (Toulouse)
  • PS2 - 055 - Immunoglobulins: Benefits and risks from the patient’s point of view - Bruno REVOL (Grenoble)
  • PS2 - 056 - Impact of the implementation of zolpidem secured prescription: the ZORRO project - Marie GERARDIN (Nantes)
  • PS2 - 057 - Treatment of allogeneic hematopoietic stem cell transplant recipients by posaconazole tablets: is therapeutic drug monitoring still useful? - Elodie GAUTIER-VEYRET (Grenoble)
  • PS2 - 058 - Cefazolin and piperacillin/tazobactam stability related to environmental factors in drug infusion bag: first step required before therapeutic drug monitoring. - David METSU (Toulouse)
  • PS2 - 059 - Biotin may interfere with laboratory tests - Julien MAHE (Nantes)
  • PS2 - 060 - Coronary artery vasospam with iron sucrose: a case report - Sylvie PICARD (Rennes)
  • PS2 - 061 - Adverse Drug Reactions of blinatumomab: a study in the French Pharmacovigilance Database - SYLVINE PINEL (Paris)
  • PS2 - 062 - A smartphone application to support prescription - Louis LÉTINIER (Bordeaux)
  • PS2 - 063 - Benzylthiouracile- Induced ANCA-Associated Vasculitis: A Case report - Fatima BENSIRADJ (Rouen)
  • PS2 - 064 - Inpatients for cocaine detoxification at Montpellier University Hospital - Hélène PEYRIERE (Montpellier)
  • PS2 - 065 - A rarely described use of neostigmine in a case of acute anticholinergic poisoning - Romain TORRENTS (Marseille)
  • PS2 - 066 - leucocytoclastic vasculitis after taking rosuvastatin : a new case - Claire LAFAY-CHEBASSIER (Poitiers)
  • PS2 - 067 - Multivisceral impairment in a DRESS Syndrome - ons CHARFI (Tunis)
  • PS2 - 068 - A one year follow up about two cases of optic neuritis under golimumab therapy (anti-TNFa) for ankylosing spondylitis revealing demyelinating disorders and multiple sclerosis - Christophe MAUCORPS (Caen)
  • PS2 - 069 - Melatonin: from pharmacokinetics to a better clinical use in Autism Spectrum Disorder - Sébastien LALANNE (Rennes)
  • PS2 - 070 - Involving children and young persons in clinical research through the forum of a European young person’s advisory group: Needs & Challenges. - Segolene GAILLARD (Lyon)
  • PS2 - 071 - Impact of the pharmacist on the potentially inappropriate medication prescriptions in older patients in ambulatory care. - Marie-Laure LAROCHE (Limoges)
  • PS2 - 072 - Efficacy of fosfomycin trometamol for the prevention of recurrent urinary tract infections in 86 patients - Sophie ISMAEL (Paris)
  • PS2 - 073 - Captopril induced acute pancreatitis associated to angioedema - Riadh DAGHFOUS (Tunis)
  • PS2 - 074 - Cutaneous reactions due to allopurinol : a report of 25 cases - Imane RAHMOUNE (Casablanca)
  • PS2 - 075 - Skin tests in hypersensitivity reactions associated with iodinated contrast media - El-Aidli SIHEM (Tunis)
  • PS2 - 076 - DRESS syndrome in an 8-year-old child associated with amoxicillin - Sihem EL-AIDLI (Tunis)
  • PS2 - 077 - Recurrent swelling of the lower lip associated with local anesthetics - Sihem EL-AIDLI (Tunis)
  • PS2 - 078 - Vancomycin-induced eruption in the setting of oral use is not that absurd: a case report and possible explanations - Farid KHELOUFI (Marseille)

Copyright © key4events - All rights reserved